Oral Contraceptive Interaction Study for GW273225

NCT00483535 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: GW273225
DRUG: COC

Sponsor

GlaxoSmithKline